NCR. Here's what you need to know about its symptoms, treatment, and easy prevention tips to keep your family safe.
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
Rationale Chronic obstructive pulmonary disease (COPD) is the most common indication for domiciliary non-invasive ventilation (NIV), but long-term outcomes data are limited. Objective This multistate ...
Background: Chronic obstructive pulmonary disease (COPD) presents a major global health burden. While FEV1/FVC is the diagnostic gold standard, its application is limited by patient compliance and ...
Genentech has announced mixed top-line results from two global clinical trials testing its treatment candidate astegolimab in people with moderate to very severe chronic obstructive pulmonary disease ...
Background Corticosteroid treatment of multiple sclerosis (MS) relapses is assumed to improve the speed of relapse recovery, without modifying long-term disability risk. We aimed to re-evaluate this ...
– The pivotal Phase IIb ALIENTO study met the primary endpoint of a statistically significant reduction in the annualized exacerbation rate (AER) at 52 weeks when astegolimab was given every two weeks ...
We reviewed evidence on the effect of action plans for exacerbations in people with chronic obstructive pulmonary disease. We found seven relevant studies. Evidence gathered in this review is current ...
This presentation was given at the American Thoracic Society (ATS) International Conference, held in San Francisco, California, USA, May 17 th −21 st, 2025. COPD is a growing problem worldwide.
Emphysema falls under the umbrella of chronic obstructive pulmonary disease (COPD). There are three main types of emphysema, and these differ according to which distinct lung parts, or lobules, they ...
COPD, asthma, and bronchiectasis are currently the three most common chronic inflammatory diseases of the airways. 1-3 However, it has not always been this way. COPD and asthma have been known for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback